Biomarker Services (CAT#: STEM-MB-0247-WXH)

a valuable tool to determine disease progression or how the drug exerts its effects in terms of safety or efficacy.
Cytokine Storm Assays to Assess Risk of Cytokine Release Syndrome
Biomarker Screening and Identification for Patient Stratification and Companion Diagnostics
Phosphorylation, Biomarker, and Analyte Determinations of Clinically Relevant Signaling Pathways
Toll-Like Receptor Panels for Infectious, Inflammatory or Neoplastic Disease
T-cell Function, T-cell Receptor, and Macrophage/Monocyte Panels for Immunomodulatory and Infective Diseases
Functional Stimulator of Interferon Gene (STING) Assays for Evaluating Pleiotropic Pathway Modulation
Platform for 3D Polycystic Kidney Disease Assays
Assays and Platforms using Human Taste Bud Epithelial Cells

Infectious diseases and cancer along with other diseases are mostly diagnosed by biomarker detection in laboratories using conventional tests such as enzyme linked immunosorbent assay (ELISA), immunofluorescence, western blotting, immunodiffusion, polymerase chain reaction (PCR), flow cytometry and a wide range of other techniques